GO:0046620 regulation of organ growth: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046620 regulation of organ growth describes any process that modulates the frequency, rate or extent of growth of an organ of an organism.
• Organ growth regulation integrates mechanical feedback, Hippo signaling, hormonal cues, and developmental scaling mechanisms.
• The Hippo pathway, via YAP and Warts, is a central conserved regulator of organ size in Drosophila and mammals.
• Disruption of organ growth control contributes to cancer, cardiac hypertrophy, and developmental disorders.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of organ growth regulators.
• Network-regulated allometry and Tctp/Coracle functions illustrate the diversity of organ growth control mechanisms.
Description
Regulation of organ growth (GO:0046620) is a fundamental biological process that ensures organs reach their appropriate size and shape during development and maintain homeostasis in adulthood. This process encompasses any mechanism that modulates the frequency, rate, or extent of organ growth, integrating genetic, mechanical, and hormonal signals. Understanding how organ growth is regulated is critical because its dysregulation underlies numerous pathological conditions, including cancer, organ hypertrophy, and developmental abnormalities. Research across model organisms, from Drosophila to plants and mammals, has revealed conserved signaling pathways such as the Hippo pathway that control organ size by coordinating cell proliferation, apoptosis, and cell competition. Mechanical feedback mechanisms also play a key role, where tissue tension and cell density provide physical cues that constrain organ growth. Additionally, hormonal signals like ecdysone in insects and developmental scaling mechanisms ensure that organs grow proportionally to body size. This article synthesizes current knowledge on the molecular players, regulatory networks, and experimental approaches used to study regulation of organ growth, providing a resource for researchers investigating this process in health and disease.
regulation of organ growth At A Glance
| GO ID | GO:0046620 |
|---|---|
| GO term | regulation of organ growth |
| Ontology | biological_process |
| Synonym | None |
| Major function | Modulates the frequency, rate or extent of organ growth |
| Key pathways | Hippo signaling, mechanical feedback, hormonal regulation |
| Model organisms | Drosophila, mouse, Arabidopsis, zebrafish |
| Disease relevance | Cancer, cardiac hypertrophy, developmental disorders |
What Is GO:0046620?
According to the Gene Ontology, regulation of organ growth (GO:0046620) is defined as any process that modulates the frequency, rate or extent of growth of an organ of an organism. This term captures the regulatory inputs that control organ size, including signaling pathways, mechanical forces, and hormonal cues that ultimately influence cell proliferation, cell growth, and apoptosis within the organ.
Why Is regulation of organ growth Important in Cell Biology?
Regulation of organ growth is essential for normal development and tissue homeostasis, and its disruption leads to a wide range of diseases including cancer, where uncontrolled organ growth manifests as tumorigenesis. Understanding the mechanisms that constrain organ size provides insights into regenerative medicine, where promoting controlled growth could aid tissue repair, and into cancer therapy, where reactivating growth-suppressive pathways is a therapeutic goal.
• Controls organ size during development and maintains tissue homeostasis in adults.
• Dysregulation causes cancer through uncontrolled cell proliferation and organ overgrowth.
• Hippo pathway components are tumor suppressors and oncogenes in human cancers.
• Mechanical feedback mechanisms prevent organ overgrowth by sensing tissue tension.
• Hormonal signals like ecdysone coordinate organ growth with developmental timing.
• Allometric scaling ensures organs grow proportionally to body size.
• Cardiac growth regulation is critical for heart development and disease.
• Plant organ growth control impacts crop yield and biomass.
• Tctp and Coracle regulate epithelial integrity and organ growth in Drosophila.
• Conserved mechanisms enable translation from model organisms to humans.
What Happens During regulation of organ growth?
Mechanical Feedback and Tissue Tension
In simple terms: Cells sense physical forces and stop growing when the organ reaches the right size.
Mechanical feedback is a key mechanism in organ growth regulation, where cells sense mechanical forces such as tension and compression within the tissue. As an organ grows, increased cell density and tissue tension generate mechanical signals that inhibit further growth, preventing overgrowth. This feedback involves the cytoskeleton and cell adhesion molecules, and is integrated with biochemical signaling pathways to coordinate cell proliferation and apoptosis.
Hippo Signaling Pathway
In simple terms: A molecular switch that turns off growth-promoting genes when organs are large enough.
The Hippo signaling pathway is a conserved regulator of organ size that controls the activity of the transcriptional co-activator YAP (Yorkie in Drosophila). When the pathway is active, a kinase cascade including Warts phosphorylates YAP, leading to its inactivation and retention in the cytoplasm, thereby limiting expression of growth-promoting genes. Inactivation of the Hippo pathway results in YAP nuclear accumulation and drives organ overgrowth, highlighting its role in cell contact inhibition and tissue growth control. Warts signaling also controls organ and body growth through regulation of ecdysone, linking growth to developmental timing.
Hormonal Regulation and Developmental Timing
In simple terms: Hormones tell organs when to grow and when to stop, coordinating with the body's developmental clock.
Hormonal signals play a critical role in regulating organ growth. In Drosophila, ecdysone, a steroid hormone, controls developmental transitions and organ growth, and Warts signaling regulates ecdysone production to coordinate growth with developmental timing. In mammals, growth hormone and insulin-like growth factors influence organ size, and cardiac growth is regulated by a complex interplay of hormonal and mechanical signals. These hormonal inputs ensure that organ growth is matched to the overall body size and developmental stage.
Network-Regulated Allometry and Scaling
In simple terms: Organs grow proportionally to the body through genetic networks that sense and adjust size.
Network-regulated allometry describes how organs scale their growth relative to body size through interconnected genetic networks. This process involves the coordinated regulation of cell number and cell size, and is influenced by nutrient sensing pathways such as insulin/TOR signaling. Studies in Drosophila and other organisms have identified genes that control morphological scaling, ensuring that organs like wings and legs reach the correct proportions. Disruption of these networks leads to allometric defects and abnormal organ size.
Epithelial Integrity and Organ Growth
In simple terms: The structure of cell layers affects how organs grow, with proteins like Tctp and Coracle maintaining tissue organization.
Epithelial integrity is closely linked to organ growth regulation. In Drosophila, Tctp and Coracle regulate epithelial integrity and organ growth, with mutations affecting cell shape, adhesion, and proliferation. These proteins influence the Hippo pathway and other growth-regulatory signals, demonstrating that maintaining tissue architecture is essential for proper organ size control. Loss of epithelial integrity can lead to uncontrolled growth and tumorigenesis.
Key Genes Involved in GO:0046620 regulation of organ growth
The following genes and proteins are key players in the regulation of organ growth across model organisms, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| YAP1 | Transcriptional co-activator promoting organ growth; inhibited by Hippo pathway | Oncogene in multiple cancers; target for growth inhibition |
| WWTR1 (TAZ) | Paralog of YAP; promotes cell proliferation and organ growth | Implicated in cancer and tissue regeneration |
| STK3/STK4 (MST1/2) | Upstream kinases in Hippo pathway that phosphorylate LATS1/2 | Tumor suppressors; loss leads to organ overgrowth |
| LATS1/LATS2 | Kinases that phosphorylate YAP/TAZ, leading to their inactivation | Tumor suppressors; mutations in cancers |
| NF2 | Fermitin family member that activates Hippo pathway | Tumor suppressor; mutated in neurofibromatosis type 2 |
| WWC1 (KIBRA) | Upstream regulator of Hippo pathway | Modulates organ size; potential tumor suppressor |
| FRMD6 | Upstream activator of Hippo pathway | Regulates organ growth; implicated in cancer |
| Drosophila wts (Warts) | Kinase in Hippo pathway; controls organ and body growth via ecdysone | Model for organ size control and hormonal regulation |
| Drosophila yki (Yorkie) | Transcriptional co-activator; promotes organ growth | Key effector of Hippo pathway in Drosophila |
| Drosophila Tctp | Regulates epithelial integrity and organ growth | Model for growth control and epithelial organization |
| Drosophila Coracle | Maintains epithelial integrity and organ growth | Model for cell adhesion and growth regulation |
| Arabidopsis ANT | Transcription factor controlling plant organ growth | Regulates cell proliferation in leaves and floral organs |
| Arabidopsis KLU | Cytochrome P450 involved in plant organ growth | Controls cell proliferation and organ size |
| Arabidopsis EXP10 | Expansin involved in cell wall loosening and organ growth | Promotes cell expansion and organ size |
| Mouse Yap1 | Regulates cardiac growth and size | Model for heart development and disease |
| Mouse Taz | Regulates cardiac growth and size | Model for heart development and disease |
| Human TTN | Titin; regulates cardiac growth and size | Mutations cause cardiomyopathy |
| Human MYH7 | Myosin heavy chain; regulates cardiac growth | Mutations cause hypertrophic cardiomyopathy |
How Is regulation of organ growth Regulated?
Regulation of organ growth is controlled by a complex network of signaling pathways, including the Hippo pathway, mechanical feedback, and hormonal signals. The Hippo pathway integrates cell density and mechanical cues to phosphorylate and inactivate YAP/TAZ, thereby restricting organ growth. Mechanical feedback mechanisms sense tissue tension and regulate cell proliferation and apoptosis to maintain organ size. Hormonal signals such as ecdysone in Drosophila and growth hormone in mammals coordinate organ growth with developmental timing and nutritional status. Additionally, network-regulated allometry ensures proportional growth through genetic networks that respond to body size.
regulation of organ growth and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| YAP1 | Cancer (multiple solid tumors) | Knockout and overexpression in cancer cell lines and mouse models |
| NF2 | Neurofibromatosis type 2 | Knockout mouse models and patient-derived cells |
| TTN | Cardiomyopathy | Knock-in mouse models and iPSC-derived cardiomyocytes |
| MYH7 | Hypertrophic cardiomyopathy | Knock-in mouse models and iPSC-derived cardiomyocytes |
| Drosophila wts | Organ overgrowth and developmental timing defects | Hypomorphic mutants and overexpression in Drosophila |
Cancer
Dysregulation of organ growth control is a hallmark of cancer. Inactivation of the Hippo pathway or overexpression of YAP/TAZ leads to uncontrolled cell proliferation and organ overgrowth, contributing to tumorigenesis in multiple tissues. YAP is a potent oncogene, and its nuclear accumulation is observed in various human cancers, making it a therapeutic target.
Cardiac Hypertrophy and Heart Disease
Cardiac growth and size are tightly regulated, and disruptions lead to pathological hypertrophy or heart failure. The Hippo pathway and its effectors YAP/TAZ play critical roles in cardiomyocyte proliferation and heart size, and their manipulation holds promise for cardiac regeneration. Mutations in sarcomeric genes such as TTN and MYH7 cause cardiomyopathies characterized by abnormal cardiac growth.
Developmental Disorders
Abnormal organ growth regulation during development can cause congenital malformations and growth disorders. For example, mutations in Hippo pathway components like NF2 cause neurofibromatosis type 2, characterized by benign tumors in the nervous system. Allometric defects can lead to disproportionate organ sizes, affecting function.
From regulation of organ growth-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate organ size? | Knockout in mouse or Drosophila |
| Does a point mutation in gene X affect organ growth? | Point mutation knock-in in mouse or zebrafish |
| Does overexpression of gene X cause organ overgrowth? | Transgenic overexpression in Drosophila or mouse |
| Where is protein X localized during organ growth? | Tagged knock-in (e.g., GFP) in model organism |
| What is the transcriptional response to growth signals? | RNA-seq in knockout and wild-type organs |
| How does gene X affect cardiac growth? | Cardiac-specific knockout or overexpression in mouse |
How to Study the regulation of organ growth Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function phenotype | Testing if a gene is required for organ growth |
| RNAi knockdown | Gene silencing effect | Tissue-specific growth studies in Drosophila |
| Overexpression | Gain-of-function phenotype | Testing if a gene drives organ overgrowth |
| Confocal imaging | Organ size, cell number, cell size | Morphometric analysis of growth phenotypes |
| RNA-seq | Transcriptional changes | Identifying downstream targets of growth pathways |
| Proteomics | Protein abundance and modifications | Studying Hippo pathway signaling |
| Immunohistochemistry | Protein localization and tissue architecture | Assessing YAP nuclear localization |
| Live imaging | Cell dynamics during growth | Tracking proliferation and apoptosis |
Genetic Knockout and Knockdown
CRISPR/Cas9-mediated knockout and RNA interference are widely used to study loss-of-function phenotypes in organ growth. Knockout of Hippo pathway components like YAP or LATS leads to organ overgrowth, demonstrating their role in growth suppression. In Drosophila, genetic mosaics and RNAi enable tissue-specific knockdown to assess organ size phenotypes.
Overexpression and Gain-of-Function Studies
Overexpression of growth-promoting genes such as YAP or Tctp results in organ overgrowth, confirming their sufficiency in driving growth. Transgenic models in Drosophila and mouse allow tissue-specific overexpression to study organ size regulation.
Imaging and Morphometrics
Confocal imaging and morphometric analysis quantify organ size, cell number, and cell size. These methods are essential for assessing growth phenotypes in model organisms. Live imaging can track cell proliferation and apoptosis during organ growth.
Transcriptomics and Proteomics
RNA-seq and proteomics identify gene expression changes downstream of growth-regulatory pathways. For example, transcriptomic profiling of YAP-overexpressing tissues reveals target genes involved in proliferation. Proteomic approaches can uncover post-translational modifications of Hippo pathway components.
How CRISPR Can Be Used to Study GO:0046620 regulation of organ growth
Knockout
CRISPR knockout is used to delete genes involved in organ growth regulation, such as YAP1 or LATS1, to assess their requirement for normal organ size. Knockout of growth suppressors leads to organ overgrowth, while knockout of growth promoters results in smaller organs. These models are valuable for validating gene function in vivo.
Point Mutation
Point mutations can be introduced to mimic disease-associated variants or to disrupt specific phosphorylation sites in growth regulators. For example, mutating YAP phosphorylation sites prevents its inactivation by the Hippo pathway, leading to constitutive growth promotion. Such models help dissect signaling mechanisms.
Knock-in
Knock-in of reporter tags (e.g., GFP) or conditional alleles allows visualization and temporal control of gene expression. Tagged knock-in of Hippo pathway components enables live imaging of protein localization during organ growth. Conditional knock-in can also model human mutations in mice.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression is used to increase gene dosage and study sufficiency in organ growth. Overexpression of YAP or Tctp drives organ overgrowth, providing insights into growth-promoting mechanisms. These models are useful for identifying downstream effectors.
How EDITGENE Supports regulation of organ growth Research
Researchers studying regulation of organ growth-related genes often need to determine whether a candidate gene is causally involved in controlling organ size, and CRISPR-based models provide the most direct approach for such functional validation. EDITGENE offers a comprehensive suite of services to support these studies.
Contact EDITGENE today to design your custom CRISPR model for regulation of organ growth research.
Frequently Asked Questions About regulation of organ growth
What is GO:0046620 regulation of organ growth?
GO:0046620 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate or extent of growth of an organ of an organism.
What genes are involved in regulation of organ growth?
Key genes include YAP1, WWTR1 (TAZ), STK3/STK4, LATS1/LATS2, NF2, and Drosophila wts and yki, among others.
How does the Hippo pathway regulate organ growth?
The Hippo pathway phosphorylates and inactivates YAP/TAZ, preventing their nuclear accumulation and thereby limiting expression of growth-promoting genes.
What is mechanical feedback in organ growth?
Mechanical feedback refers to the process where cells sense physical forces like tension and compression to inhibit growth when the organ reaches the correct size.
Which model organisms are used to study organ growth regulation?
Drosophila, mouse, zebrafish, and Arabidopsis are commonly used to study organ growth regulation.
How is organ growth regulated by hormones?
Hormones such as ecdysone in Drosophila and growth hormone in mammals coordinate organ growth with developmental timing and nutritional status.
What diseases are associated with dysregulated organ growth?
Cancer, cardiac hypertrophy, and developmental disorders are linked to defects in organ growth regulation.
How can CRISPR be used to study organ growth?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional testing of genes involved in organ growth regulation.
What is network-regulated allometry?
Network-regulated allometry is the developmental regulation of morphological scaling, ensuring organs grow proportionally to body size through genetic networks.
What methods are used to measure organ growth?
Methods include confocal imaging, morphometrics, RNA-seq, proteomics, and live imaging to quantify organ size and cell dynamics.
Conclusion
Regulation of organ growth (GO:0046620) is a central biological process that integrates mechanical, hormonal, and genetic signals to control organ size. The Hippo pathway and its effectors YAP/TAZ are key regulators, and their dysregulation leads to cancer and other diseases. Understanding these mechanisms offers opportunities for therapeutic intervention and regenerative medicine. CRISPR-based models are indispensable for dissecting the causal roles of specific genes in organ growth, and EDITGENE provides comprehensive services to support such research.
References
- 1. Buchmann A et al.. 2014. Sizing it up: the mechanical feedback hypothesis of organ growth regulation.. Semin Cell Dev Biol 35:73-81 PMID: 25020200
- 2. Zhao B et al.. 2007. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control.. Genes Dev 21(21):2747-61 PMID: 17974916
- 3. Vea IM et al.. 2021. Network-regulated organ allometry: The developmental regulation of morphological scaling.. Wiley Interdiscip Rev Dev Biol 10(3):e391 PMID: 32567243
- 4. Lee SR et al.. 2020. Regulation of epithelial integrity and organ growth by Tctp and Coracle in Drosophila.. PLoS Genet 16(6):e1008885 PMID: 32559217
- 5. Johnson K et al.. 2011. Genetic control of plant organ growth.. New Phytol 191(2):319-333 PMID: 21517873
- 6. Moeller ME et al.. 2017. Warts Signaling Controls Organ and Body Growth through Regulation of Ecdysone.. Curr Biol 27(11):1652-1659.e4 PMID: 28528906
- 7. Kango-Singh M et al.. 2009. Regulation of organ size: insights from the Drosophila Hippo signaling pathway.. Dev Dyn 238(7):1627-37 PMID: 19517570
- 8. Heallen TR et al.. 2020. Determinants of Cardiac Growth and Size.. Cold Spring Harb Perspect Biol 12(3) PMID: 31615785
